Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Bafiertam

(L-Nitro-Monomethyl-Arginine /kg IV)

Biologic

BBanner Life Sciences LLC

0

Indications

1

Total Trials

0

Active Trials

0

Competitors

1

FDA Application

NDA/BLA/ANDA regulatory filings

Clinical

Trials by Indication[1]

Nitric Oxide1 trial

Nitric Oxide Control of Migrating Motor Complex: L-NMMA Effects in Relation to Receptor Blockades

Completed·UUppsala University·Phase 1·NCT02245165·29 enrolled

Regulatory

FDA Approval Timeline[3]

Apr 28, 2020

BAFIERTAM

NDA NDA210296

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for L-Nitro-Monomethyl-Arginine /kg IV. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — L-Nitro-Monomethyl-Arginine /kg IV compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
OpenFDA — FDA approval records (NDA NDA210296). U.S. Food & Drug Administration.
[4]
SEC EDGAR — Banner Life Sciences LLC company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Company: BBanner Life Sciences LLC

Related News